Lexicon Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Lexicon Pharmaceuticals Inc.
Fidelity Growth Company Fund
6,837,680
6.46%
-2,177
0.16%
07/31/2018
Fidelity Series Growth Company Fund
1,986,777
1.88%
9,599
0.17%
07/31/2018
Fidelity Select Biotechnology Portfolio
1,978,704
1.87%
0
0.25%
07/31/2018
iShares Nasdaq Biotechnology ETF
1,228,680
1.15%
-16,065
0.14%
09/06/2018
UBS (Lux) Equity Fund - Biotech
1,131,816
1.07%
0
1.06%
01/31/2018
Vanguard Small Cap Index Fund
1,066,376
1.01%
11,161
0.01%
07/31/2018
SPDR S&P Biotech ETF
1,057,877
1%
2,721
0.21%
09/06/2018
Vanguard Total Stock Market Index Fund
1,052,238
0.99%
0
0%
07/31/2018
iShares Russell 2000 ETF
912,017
0.86%
-486
0.02%
09/06/2018
ClearBridge Special Investment Trust
900,040
0.85%
0
0.88%
01/31/2018
| Address |
8800 Technology Forest Place
The Woodlands Texas 77381
United States
|
|
Employees
|
- |
| Website |
http://www.lexpharma.com |
| Updated |
07/08/2019 |
| Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It also offers programs in clinical development for diabetes, irritable bowel syndrome, and carcinoid syndrome. The company was founded by Brian P. |
